Cellectar Biosciences Inc...
0.26
-0.02 (-5.45%)
At close: Jan 15, 2025, 10:01 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -11.00K 33.33K 96.31K 125.97K n/a n/a 12.58K 4.96K
Cost of Revenue 192.38K 238.87K 227.64K 207.93K 189.36K 82.27K 1.55M 356.67K 362.50K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.54K
Gross Profit -192.38K -238.87K -227.64K -207.93K -189.36K -82.27K -1.55M -356.67K -362.50K n/a n/a n/a -11.00K 33.33K 96.31K 125.97K n/a n/a 12.58K 2.42K
Operating Income -38.96M -28.81M -24.13M -15.29M -14.18M -13.33M -13.60M -9.45M -8.76M -9.89M -12.40M -8.75M -7.04M -5.45M -10.17M -16.59M -20.29M -8.93M -5.09M -625.22K
Interest Income n/a 152.52K 2.28K 10.90K 42.71K n/a n/a n/a n/a n/a n/a 1K 4.50K 2.42K 1.01K 130.61K 729.92K 637.75K 49.88K 95.00
Pretax Income -38.04M -28.66M -24.12M -15.09M -14.09M -13.24M -13.56M -6.18M -5.50M -8.11M -10.78M -8.80M -7.75M -12.65M -26.28M -22.96M -29.72M -8.55M -3.16M -815.28K
Net Income -37.98M -28.60M -23.97M -14.76M -13.87M -13.24M -13.56M -6.18M -5.50M -8.11M -10.78M -8.80M -7.44M 2.10M -22.27M -16.45M -19.56M -8.29M -3.05M -815.28K
Selling & General & Admin 11.69M 9.59M 6.54M 5.15M 5.18M 4.82M 4.14M 4.70M 3.40M 3.70M 4.44M 3.63M 2.69M 2.49M 2.18M 2.19M 2.87M 2.49M 1.44M 365.88K
Research & Development 27.27M 19.22M 17.59M 10.14M 9.00M 6.84M 9.47M 4.75M 5.16M 5.96M 6.86M 5.12M 3.60M 3.00M 8.08M 14.53M 17.43M 6.44M 1.14M 261.77K
Other Expenses -0.00 n/a 6.63K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 38.96M 28.81M 24.13M 15.29M 14.18M 11.66M 13.60M 9.45M 8.55M 9.67M 11.30M 8.75M 6.29M 5.48M 10.26M 16.72M 20.29M 8.93M 2.58M 627.64K
Interest Expense n/a n/a n/a n/a n/a 29.69K 16.61K 7.90K 841.00 446.31K 9.35K 9.34K 430.02K 2.42K 1.01K 130.61K n/a n/a n/a 208.74K
Selling & Marketing Expenses 945.18K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 38.96M 28.81M 24.13M 15.29M 14.18M 11.66M 13.60M 9.45M 8.55M 9.67M 11.30M 8.75M 6.29M 5.48M 10.26M 16.72M 20.29M 8.93M 2.58M 630.18K
Income Tax -60.00K -60.00K -152.20K -337.63K -218.51K -1.55M -38.68K -3.27M -3.42M -1.56M -522.76K 9.34K 1.14M -7.55M 12.11M -139.61K -737.05K -643.75K 487.02K n/a
Shares Outstanding (Basic) 12.22M 7.06M 5.55M 1.98M 767.51K 296.20K 140.31K 43.67K 7.82K 4.59K 2.79K 2.06K 1.20K 147.00 22.00 14.00 12.00 12.00 12.00 4.52
Shares Outstanding (Diluted) 12.22M 7.06M 5.55M 1.98M 767.51K 296.20K 140.31K 43.67K 7.82K 4.59K 2.79K 2.06K 1.20K 147.00 22.00 14.00 12.00 12.00 12.00 4.52
EPS (Basic) -3.11 -4.05 -4.32 -7.45 -18.08 -44.7 -96.66 -141.54 -702.78 -1.77K -3.86K -4.28K -6.21K -31.02K -1.01M -1.18M -1.63M -690.50K -254.45K -180.51K
EPS (Diluted) -3.11 -4.05 -4.32 -7.45 -18.08 -44.7 -96.66 -141.54 -702.78 -1.77K -3.86K -4.28K -6.21K -31.02K -1.01M -1.18M -1.63M -690.50K -254.45K -180.51K
EBITDA -38.77M -28.67M -23.98M -15.15M -13.90M -13.16M -12.05M -9.09M -8.19M -9.30M -10.88M -8.29M -6.33M -12.96M -10.17M -16.59M -19.54M -8.28M -2.94M -604.01K
Depreciation & Amortization 192.38K 238.87K 227.64K 207.93K 189.36K 82.27K 1.55M 356.67K 362.50K 367.20K 424.76K 497.25K 584.84K 35.34K 32.35K 16.89K 15.37K 9.52K 3.24K 2.54K